Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Cost of Revenue (2016 - 2025)

China Pharma Holdings' Cost of Revenue history spans 16 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 185.47% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $5.5 million, up 932.75%, while the annual FY2025 figure was $4.3 million, 708.63% up from the prior year.
  • Cost of Revenue reached $4.0 million in Q4 2025 per CPHI's latest filing, up from $78041.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $4.0 million in Q4 2025 to a low of -$4.7 million in Q4 2024.
  • Average Cost of Revenue over 5 years is $525445.0, with a median of $457618.5 recorded in 2021.
  • Peak YoY movement for Cost of Revenue: soared 892.62% in 2023, then tumbled 1907.41% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $536902.0 in 2021, then plummeted by 966.06% to -$4.6 million in 2022, then surged by 105.58% to $259552.0 in 2023, then crashed by 1907.41% to -$4.7 million in 2024, then soared by 185.47% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Cost of Revenue are $4.0 million (Q4 2025), $78041.0 (Q3 2025), and $101292.0 (Q2 2025).